Skip to main content
Cybin Inc. logo

Cybin Inc. - Investor Relations & Filings

Listed IPO Sep 2019
Ticker · HELP ISIN · CA23256X4075 LEI · 549300NTYWN4CVYSCN32 NEO Manufacturing
Open in API
Filings indexed 1,072 across all filing types
Latest filing 2026-04-20 Board/Management Inform…
Country CA Canada
Listing NEO HELP · 9 venues

Key figures FY2025

Period ended 2025-03-31 · CAD
Headline annual figures for Cybin Inc., fiscal year 2025, reported in CAD, with the source filing for each figure.
Net Income CAD -113.14M per the Audit Report / Information filed 2025-07-01
Total Assets CAD 258.62M per the Audit Report / Information filed 2025-07-01
Total Equity CAD 237.20M per the Audit Report / Information filed 2025-07-01
Cash from Ops CAD -101.30M per the Audit Report / Information filed 2025-07-01

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Cybin Inc.

http://www.cybin.com

Cybin Inc. is a clinical-stage biopharmaceutical company specializing in breakthrough neuropsychiatry, committed to developing next-generation therapeutics to revolutionize mental healthcare. The company utilizes proprietary drug discovery platforms to innovate Novel Serotonergic Agonists (NSAs)—synthetic molecules designed to activate serotonin pathways and promote neuroplasticity—paired with precision drug delivery systems. A core technological differentiator is the use of deuteration technology to create treatments with consistent delivery and commercial scalability. Cybin maintains a robust intellectual property portfolio, including over 100 granted patents and 250 pending applications, supporting its active drug programs, such as CYB004, currently in Phase 2 clinical trials for the treatment of Generalized Anxiety Disorder. The mission is to provide treatments designed to foster durable improvements in mental health.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing a change in the company's Chief Executive Officer, specifically the stepping down of the current CEO and the appointment of an interim CEO. It includes background information about the company, forward-looking statements, and contact information. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content focuses on management changes at the executive level, which aligns with announcements about changes in senior management or the board of directors. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (8650 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive management change announcement.
2026-04-20 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing a change in the company's Chief Executive Officer, specifically the stepping down of the current CEO and the appointment of an interim CEO. It includes background information about the company, forward-looking statements, and contact information. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content focuses on management changes at the executive level, which aligns with announcements about changes in senior management or the board of directors. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (8650 characters) is sufficient to be a full announcement rather than a brief note or a report publication announcement. Hence, the classification is MANG with high confidence.
2026-04-20 English
6-K - CYBIN INC. (0001833141) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed pursuant to SEC rules under the Securities Exchange Act of 1934. It is dated April 16, 2026, and includes a signature from the CFO and an exhibit index referencing a news release. The document length is short (1155 characters), and it does not contain detailed financial statements or substantive financial data. It is a regulatory filing to inform the SEC and investors about current events or updates from the foreign issuer, not a full annual or quarterly report, earnings release, or other detailed report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2026-04-16 English
News release - English.pdf
Audit Report / Information Classification · 95% confidence The document is a standalone Independent Auditor’s Report including the auditor’s opinion, basis for opinion, key audit matters, and responsibilities on the Group’s consolidated financial statements for the years ended December 31, 2025 and 2024. It does not represent a full Annual Report or management discussion beyond audit scope. This aligns with the definition of Audit Report / Information (AR). FY 2025
2026-04-16 English
News release - English.pdf
Board/Management Information Classification · 90% confidence The document is a company press release announcing a senior leadership appointment (Dr. Ken Kramer as SVP, Medical Affairs). It does not present financial results, call transcripts, regulatory filings, or proxy materials. It clearly constitutes an announcement of a change in senior management, matching the Board/Management Information category.
2026-04-16 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a corporate press release announcing the appointment of a new Senior Vice President, Medical Affairs. It focuses on changes in senior management personnel and their background, which matches the definition of a Board/Management Information filing. It does not contain financial results, regulatory disclosures about voting, or other report attachments. Therefore, it is classified as MANG (Board/Management Information).
2026-04-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.